Journal of Vascular Surgery

Syndicate content
Journal of Vascular Surgery RSS feed.
Updated: 3 hours 21 min ago

Invited commentary

May 1, 2019 - 00:00
Endovascular aneurysm repair has become standard of care. The short-term outcomes are well established and long-term outcomes are now being adjudicated to determine the indications for treatment in different populations. Part of the refinement of indications requires the delicate decision of whether to proceed in cases in which patients have a compromised quality of life or when the quality of life is good but the high comorbid risk makes the likelihood of a complication great. The question of whether to live with an unrepaired aneurysm often involves more art than science to answer as it requires determining the patient's motivation for living and the elements of life that provide the most joy and choosing the path that puts those elements at lowest risk.

RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling

May 1, 2019 - 00:00
Current drug-eluting stent (DES) treatment is promising, but it still has the drawback of in-stent restenosis, which remains a clinically relevant problem. Efforts should be made to discover new signaling molecules and novel potential targets for the prevention of arterial restenosis. In this study, we fabricated a novel DES targeting the RhoA pathway and further examined this promising strategy in vitro and in a rabbit carotid model.

Discussion

April 10, 2019 - 00:00
Kristofer M. Charlton-Ouw (Houston, Tex). Thank you for an on-time, concise, and well-written paper. The authors adjusted for many of the known risks of spinal cord ischemia (SCI) but can only adjust for associations that we know about. I did not see hypogastric artery status or length of aortic coverage listed.

Systematic review and meta-analysis of elective and urgent late open conversion after failed endovascular aneurysm repair

April 3, 2019 - 23:00
In this study, we systematically reviewed late open conversions after failed endovascular aneurysm repair (EVAR), assessed the methodologic quality of the included studies, and performed a meta-analysis on the 30-day mortality rates for urgent and elective late conversions.

Journal of Vascular Surgery – April 2019 Audiovisual Summary

March 31, 2019 - 23:00
Welcome the April issue of the Journal of Vascular Surgery. We have four outstanding papers for you to read for free, as well as many other outstanding papers.

Events of interest

March 31, 2019 - 23:00
News items of interest to the vascular surgeon must be received at least 8 weeks before the desired month of publication. Announcements published at no charge include those received from a sponsoring society of this Journal, those courses and conferences sponsored by state, regional, national, or international vascular surgical organizations, and university-sponsored continuing medical education courses. Send applicable events to Andrew O’Brien, Journal Manager, at a.obrien@elsevier.com. All other news items selected for publication carry a charge of $60.00 US for each insertion, and the fee must accompany the request to publish.

Information for readers

March 31, 2019 - 23:00
Communications regarding original articles and editorial management should be addressed to Peter Gloviczki, MD, and Peter F. Lawrence, MD, Editors, Journal of Vascular Surgery, 9400 W. Higgins Road, Suite 315, Rosemont IL 60018; telephone: 603-523-2222; fax: 312-334-2320; e-mail: JVASCSURG@vascularsociety.org. Information for authors appears in the January and July issues, at www.jvascsurg.org, and at jvs.editorialmanager.com. Authors should consult this document before submitting manuscripts to this Journal.

Contents

March 31, 2019 - 23:00

Editorial Board

March 31, 2019 - 23:00

Correction

March 31, 2019 - 23:00
In the February 2019 issue of the Journal of Vascular Surgery, the article by Bleyer et al (Bleyer AJ, Scavo VA, Wilson SE, Browne BJ, Ferris BL, Ozaki CK, et al. A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis. J Vasc Surg 2019;69:507-15) contained a typo in the manufacturer name of VasCore. The correct name is VasCore and not VasCare as published.

Hemodialysis access creation episode-based cost measure

March 31, 2019 - 23:00
The Medicare Access and Children's Health Insurance Program Reauthorization Act (MACRA) established the Quality Payment Program. The Quality Payment Program requires providers who bill Medicare to participate in the Merit-based Incentive Payment System (MIPS) or an Advanced Alternative Payment Model. Most vascular surgeons will participate in MIPS as no Advanced Alternative Payment Model is approved for vascular surgery. Failure to participate adequately in MIPS in 2019 will result in a 7% penalty in 2021 reimbursements.

Correction

March 31, 2019 - 23:00
1/6/2018

Weekend Effect in Carotid Endarterectomy

March 31, 2019 - 23:00
A review was conducted of the Vascular Quality Initiative between 2003 and 2018.

Strategy for the Treatment of Spontaneous Isolated Visceral Artery Dissection

March 31, 2019 - 23:00
This was a single-center retrospective review from 2005 to 2016.

Management of Common Femoral Artery Occlusive Disease: A Review of Endovascular Treatment Strategies and Outcomes

March 31, 2019 - 23:00
A review of 21 studies from 1987 to 2018 was performed.

Antiplatelet Therapy for Peripheral Artery Disease

March 31, 2019 - 23:00
A review was conducted of registries, randomized trials, and meta-analysis publications from PubMed between 1994 and 2018 and on-line clinical trials in 2018.

Hospital Volume Matters: The Volume-Outcome Relationship in Open Juxtarenal AAA Repair

March 31, 2019 - 23:00
A review was conducted of the Vascular Quality Initiative between 2003 and 2016.

A Systematic Literature Review of Patients with Carotid Web and Acute Ischemic Stroke

March 31, 2019 - 23:00
A search was conducted of MEDLINE through PubMed (1946-December 15, 2017), Embase through Ovid (1947-week 50, 2017), and the Cochrane Library through Wiley (ending December 15, 2017).

Reply

March 31, 2019 - 23:00
We appreciate the excellent comment by Botes et al. The highlighted improvements in abdominal aortic aneurysm (AAA) repair in the United Kingdom give evidence of the value of real-world data use, and the authors should be congratulated for being a part of this outstanding success of ongoing changes in vascular services in Great Britain. Widespread adoption of endovascular aneurysm repair (EVAR)1,2 and the ongoing centralization of AAA repairs3,4 can be seen as the cause of improvements in both intact and ruptured AAA repairs.

Regarding “Impact of weekend treatment on short-term and long-term survival after urgent repair of ruptured aortic aneurysms in Germany”

March 31, 2019 - 23:00
Behrendt et al1 should be congratulated on their work identifying worse in-hospital survival rates for patients treated for ruptured abdominal aortic aneurysm (rAAA) at the weekend in Germany. The “weekend effect” has received much attention since 2001, when it was first described in a population of Canadian patients undergoing repair of rAAA.